{"id":"W4417183496","doi":"10.1038/s41581-025-01031-3","title":"The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup","year":2025,"lang":"en","type":"article","venue":"Nature Reviews Nephrology","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health; CytoSorbents Europe; Akebia Therapeutics; National Institute for Health and Care Research; BioPorto; Prothena; Alexion Pharmaceuticals; GlaxoSmithKline; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen; Pfizer; Sphingotec GmbH; Mersana Therapeutics; Science and Engineering Research Board; Fresenius Medical Care North America; Nipro; American Society of Nephrology; AstraZeneca; Eli Lilly and Company","keywords":"Workgroup; Nephrotoxicity; Kidney disease; Acute kidney injury; Dosing; Disease; Chimeric antigen receptor; Renal replacement therapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08388221,0.001529421,0.005246685,0.004086608,0.001486638,0.005327614,0.005878828,0.00327836,0.001581461],"category_scores_gemma":[0.07066993,0.0008343367,0.008524395,0.005156147,0.001535823,0.002504264,0.005637718,0.006822501,0.000783032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007720725,"about_ca_system_score_gemma":0.03054386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.025643,"about_ca_topic_score_gemma":0.03968277,"domain_scores_codex":[0.9633046,0.01097708,0.009704919,0.001728867,0.01259931,0.001685163],"domain_scores_gemma":[0.873629,0.03960777,0.03080455,0.002567512,0.04356982,0.009821294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002748123,0.0005001804,0.05787362,0.05780711,0.01030747,0.0002197976,0.001427454,0.00323107,0.001306047,0.008122087,0.2829627,0.5734943],"study_design_scores_gemma":[0.003260445,0.001058335,0.1632304,0.159606,0.01860399,0.0006246553,0.003012641,0.002669001,0.00338573,0.01124055,0.6327194,0.0005887429],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01713889,0.7356589,0.01097088,0.1827174,0.01507093,0.00267657,0.01488147,0.000349336,0.02053552],"genre_scores_gemma":[0.1702743,0.6357431,0.05967418,0.08585098,0.009662519,0.006075526,0.02859075,0.0004526126,0.003675996],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.08388221,"threshold_uncertainty_score":0.4436169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01728514060501832,"score_gpt":0.3594748740111576,"score_spread":0.3421897334061393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}